Belite Bio (BLTE) Cash & Current Investments (2021 - 2025)

Belite Bio's Cash & Current Investments history runs 5 years deep, the most recent figure standing at $476.8 million for Q4 2025.

• In Q4 2025, Cash & Current Investments rose 239.1% year-over-year to $476.8 million; the TTM figure through Dec 2025 stood at $476.8 million (up 239.1% YoY), while the FY2025 annual figure was $476.8 million, up 239.1% from the prior year.
• Cash & Current Investments was $476.8 million for Q4 2025 at Belite Bio, up from $31.7 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $476.8 million in Q4 2025 to a low of $17.3 million in Q4 2021.
• Historically, Cash & Current Investments has averaged $126.4 million across 5 years, with a median of $88.2 million in 2023.
• Biggest YoY gain for Cash & Current Investments was 239.1% in 2025; the steepest drop was 64.07% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $17.3 million in 2021, then surged by 142.67% to $42.1 million in 2022, then jumped by 109.45% to $88.2 million in 2023, then surged by 59.49% to $140.6 million in 2024, then surged by 239.1% to $476.8 million in 2025.
• The last three Cash & Current Investments figures came in at $476.8 million (Q4 2025), $31.7 million (Q3 2025), and $140.6 million (Q4 2024), per Business Quant data.